← Open Payments lookup

SARA RYGOL: Open Payments

NPI 1184657603 · COUNCIL BLUFFS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,087 in 105 payments from 20 companies in 2025. Trend: 2023 $1,670 · 2024 $2,493 · 2025 $4,087

Consulting: $2,000Food & beverage: $1,960Education: $127
CompanyPaymentsAmount
ABBVIE INC.37$2,713
AstraZeneca Pharmaceuticals LP13$295
Novo Nordisk Inc13$204
Astellas Pharma US Inc4$170
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$106
Otsuka America Pharmaceutical, Inc.5$94
Lilly USA, LLC5$91
PFIZER INC.5$80
Gilead Sciences, Inc.2$49
Vanda Pharmaceuticals Inc.2$45

Products named: QULIPTA, VRAYLAR, UBRELVY, Ozempic, REXULTI, CAPLYTA, LINZESS, FARXIGA.

Industry payments across IA — which companies pay providers there.